Piramal Pharma reports consolidated net loss of Rs 136.19 crore in the December 2025 quarter
Sales decline 2.92% to Rs 2139.87 crore
Net loss of Piramal Pharma reported to Rs 136.19 crore in the quarter ended December 2025 as against net profit of Rs 3.68 crore during the previous quarter ended December 2024. Sales declined 2.92% to Rs 2139.87 crore in the quarter ended December 2025 as against Rs 2204.22 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales2139.872204.22 -3 OPM %9.1515.32 -PBDT159.99263.61 -39 PBT-52.7566.80 PL NP-136.193.68 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content